Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Operating Expenses | 1,103 | 1,656 | 1,847 | 888 | 1,468 |
| Operating Income | -1,103 | -1,656 | -1,847 | -888 | -1,468 |
| Interest Expense | N/A | N/A | N/A | 3 | 12 |
| Other Income | 521 | -411 | 13 | -371 | -82 |
| Pre-tax Income | -582 | -2,067 | -1,834 | -1,262 | -1,562 |
| Income Tax | -7 | 9 | 3 | N/A | N/A |
| Net Income Continuous | -575 | -2,076 | -1,837 | -1,291 | -1,562 |
| Net Income | $-575 | $-2,076 | $-1,837 | $-1,291 | $-1,562 |
| EPS Basic Total Ops | -2.40 | -16.50 | -32.10 | -46.20 | -45.00 |
| EPS Basic Continuous Ops | -2.40 | -16.50 | -32.10 | -46.20 | -45.00 |
| EPS Diluted Total Ops | -2.40 | -16.50 | -32.10 | -48.22 | -45.00 |
| EPS Diluted Continuous Ops | -2.40 | -16.50 | -32.10 | -48.22 | -45.00 |
| EBITDA(a) | $-1,085 | $-1,639 | $-1,828 | $-1,235 | $-1,503 |